In vivo methods for the assessment of topical drug bioavailability

被引:189
|
作者
Herkenne, Christophe [1 ,2 ]
Alberti, Ingo [1 ,3 ]
Naik, Aarti [1 ]
Kalia, Yogeshvar N. [1 ]
Mathy, Franois-Xavier [4 ,5 ]
Preat, Veronique [4 ]
Guy, Richard H. [1 ,6 ]
机构
[1] Univ Geneva, Sch Pharmaceut Sci, CH-1211 Geneva 4, Switzerland
[2] Debio Rech Pharmaceut, CH-1920 Martigny, Switzerland
[3] Antares Pharma AG, CH-4123 Allschwil, Switzerland
[4] Catholic Univ Louvain, Unite Pharma Galeniq Ind & Officinale, B-1200 Brussels, Belgium
[5] UCB Bioprod SA, B-1420 Braine LAlleud, Belgium
[6] Univ Bath, Dept Pharm & Pharmacol, Bath BA2 7AY, Avon, England
关键词
cutaneous bioavailability; cutaneous drug concentration; dermatopharmacokinetics; microdialysis; tape stripping;
D O I
10.1007/s11095-007-9429-7
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
This paper reviews some current methods for the in vivo assessment of local cutaneous bioavailability in humans after topical drug application. After an introduction discussing the importance of local drug bioavailability assessment and the limitations of model-based predictions, the focus turns to the relevance of experimental studies. The available techniques are then reviewed in detail, with particular emphasis on the tape stripping and microdialysis methodologies. Other less developed techniques, including the skin biopsy, suction blister, follicle removal and confocal Raman spectroscopy techniques are also described.
引用
收藏
页码:87 / 103
页数:17
相关论文
共 50 条
  • [1] In Vivo Methods for the Assessment of Topical Drug Bioavailability
    Christophe Herkenne
    Ingo Alberti
    Aarti Naik
    Yogeshvar N. Kalia
    François-Xavier Mathy
    Véronique Préat
    Richard H. Guy
    [J]. Pharmaceutical Research, 2008, 25
  • [2] Dermatopharmacokinetic prediction of topical drug bioavailability in vivo
    Herkenne, Christophe
    Naik, Aarti
    Kalia, Yogeshvar N.
    Hadgraft, Jonathan
    Guy, Richard H.
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2007, 127 (04) : 887 - 894
  • [3] Reverse Iontophoresis: Noninvasive Assessment of Topical Drug Bioavailability
    Moore, Kieran
    Gregoire, Sebastien
    Eilstein, Joan
    Delgado-Charro, M. Begona
    Guy, Richard H.
    [J]. MOLECULAR PHARMACEUTICS, 2023, 21 (01) : 234 - 244
  • [4] Assessment of topical bioavailability in vivo: The importance of stratum corneum thickness
    Kalia, YN
    Alberti, I
    Naik, A
    Guy, RH
    [J]. SKIN PHARMACOLOGY AND APPLIED SKIN PHYSIOLOGY, 2001, 14 : 82 - 86
  • [5] Assessment and Prediction of the Cutaneous Bioavailability of Topical Terbinafine, In Vivo, in Man
    Ingo Alberti
    Yogeshvar N. Kalia
    Aarti Naik
    Richard H. Guy
    [J]. Pharmaceutical Research, 2001, 18 : 1472 - 1475
  • [6] Assessment and prediction of the cutaneous bioavailability of topical terbinafine, in vivo, in man
    Alberti, I
    Kalia, YN
    Naik, A
    Guy, RH
    [J]. PHARMACEUTICAL RESEARCH, 2001, 18 (10) : 1472 - 1475
  • [7] In vivo assessment and prediction of topical bioavailability of iodiconazole, a new triazole antifungal agent
    Wu LiLi
    Zhou Ke
    Zong WenKai
    Chen Yun
    Sheng ChunQuan
    [J]. 国际皮肤性病学杂志(英文), 2018, 1 (04)
  • [8] METHODS FOR ESTIMATING DRUG BIOAVAILABILITY PARAMETERS .3. PECULIARITIES OF PHARMACOKINETIC ANALYSIS IN ASSESSMENT OF BIOAVAILABILITY
    FIRSOV, AA
    PIOTROVSKII, VK
    [J]. PHARMAZIE, 1986, 41 (07): : 457 - 465
  • [9] Calcium bioavailability: an in vivo assessment
    Patwardhan, UN
    Pahuja, DN
    Samuel, AM
    [J]. NUTRITION RESEARCH, 2001, 21 (04) : 667 - 675
  • [10] Reverse Iontophoresis: Noninvasive Assessment of Topical Drug Bioavailability (vol 21, pg 234, 2024)
    Moore, Kieran
    Gregoire, Sebastien
    Eilstein, Joan
    Delgado-Charro, M. Begona
    Guy, Richard H.
    [J]. MOLECULAR PHARMACEUTICS, 2024, 21 (04) : 2058 - 2058